Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3447 results

Sort By:

Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy

Study ID: NCT06782542
Start Date: 2025-11-01
End Date: 2028-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

16

Intervention / Treatment

Olutasse

Venetoclax

Azacitidine

Sponsor

Justin Watts, MD

Source: clinicaltrials.gov

Share:
Add to list

Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME)

Study ID: NCT07095166
Start Date: 2025-10-15
End Date: 2027-10-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Meal Location

Sponsor

Penn State University

Source: clinicaltrials.gov

Share:
Add to list

Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut.

Study ID: NCT07144501
Start Date: 2025-09-15
End Date: 2026-03-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Ultrasonography

Blood Sampling

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer

Study ID: NCT07146919
Start Date: 2025-10-15
End Date: 2030-10-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

87

Intervention / Treatment

Bemarituzumab

Infatuating

Sponsor

Berard Leon Center

Source: clinicaltrials.gov

Share:
Add to list

Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study

Study ID: NCT06952790
Start Date: 2025-11-01
End Date: 2026-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

EveryDose Mobile Application

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Health Benefits of Tart Cherry in Crohn's Disease

Study ID: NCT06901986
Start Date: 2026-01-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

52

Intervention / Treatment

Montmorency tart cherry

Placebo

Sponsor

University of Central Lancashire

Source: clinicaltrials.gov

Share:
Add to list

LTFU for All Cell and Gene Therapy Studies

Study ID: NCT06194461
Start Date: 2025-09-17
End Date: 2041-11-29
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

64

Intervention / Treatment

AZD5851

0754

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A

Study ID: NCT07152873
Start Date: 2025-10-20
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

60

Intervention / Treatment

AD-117

AD-117A

Sponsor

Addpharma Inc.

Source: clinicaltrials.gov

Share:
Add to list

Diagnosing Epilepsy To EffeCT Change

Study ID: NCT07110337
Start Date: 2025-10
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase4

No. of Participants

210

Intervention / Treatment

Receipt of the Minder System (implantable sub-scalp continuous electroencephalographic (EEG) monitoring (iCEM) system)

Sponsor

Epiminder America, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Application to Predict Neonatal Apnea With Bradycardia

Study ID: NCT06852053
Start Date: 2025-10-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Closed-loop Vibro-Tactile Stimulator

Control

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list